UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fusobacterium nucleatum ist im Magen nachweisbar und ist mit schlechterer Prognose beim Magenkarzinom vom diffusen Typ assoziiert

Zeitschrift für Gastroenterologie, 2018, Vol.56 (8), p.e305-e305

2018

Volltextzugriff (PDF)

P569 Fecal Microbiome Transplantation for Recurrent C. difficile Colitis: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i511-i511

2022

Volltextzugriff (PDF)

Distinct microbiota in patients diagnosed with colorectal cancer compared to healthy individuals

Microbiota in health and disease, 2023-03, Vol.5

2023

Volltextzugriff (PDF)

Distinct composition and distribution of the gastric mycobiota observed between dyspeptic and gastric cancer patients evaluated from gastric biopsies

Microbiota in health and disease, 2020-09, Vol.2

2020

Volltextzugriff (PDF)

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes

Advances in radiation oncology, 2017-07, Vol.2 (3), p.308-315

2017

Volltextzugriff (PDF)

Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review

Journal of the American Academy of Dermatology, 2017-02, Vol.76 (2), p.368-374

2017

Volltextzugriff (PDF)

Controlling the stereoselectivity of rac-LA polymerization by chiral recognition induced the formation of homochiral dimeric metal alkoxidesElectronic supplementary information (ESI) available: Crystallographic data of (R,S)-1, (S,S)-2, (R,S)-2 and 3 in CIF format; 1H, 13C and PGSE NMR for 1-4; FTIR data for (S,S)-1 and (S,S)-2; details of rac-LA polymerization with (S,S)-1 and (S,S)-2; MALDI-TOF spectra of PLA. CCDC 1438998-1439001. For ESI and crystallographic data in CIF or other electronic f

2016-03

Volltextzugriff (PDF)

Assessing fear of recurrence of esophageal cancer in patients treated with esophagectomy

Michigan Journal of Medicine, 2019-05, Vol.4 (1)

2019

Volltextzugriff (PDF)

Thromboembolic Events Before Esophagectomy for Esophageal Cancer Do Not Result in Worse Outcomes

The Annals of thoracic surgery, 2012-10, Vol.94 (4), p.1118-1125

2012

Volltextzugriff (PDF)

Therapeutic interventions for vitiligo

Journal of the American Academy of Dermatology, 2008-10, Vol.59 (4), p.713-717

2008

Volltextzugriff (PDF)

Preoperative Chemoradiation for the Treatment of Locoregional Esophageal Cancer: The Standard of Care?

Seminars in radiation oncology, 2007-01, Vol.17 (1), p.45-52

2007

Volltextzugriff (PDF)

Delaying surgery for esophageal cancer increases postoperative complications

Journal of the American College of Surgeons, 2013-09, Vol.217 (3), p.S35-S36

2013

Volltextzugriff (PDF)

Propranolol and metoprolol enhance the anticonvulsant action of valproate and diazepam against maximal electroshock

Pharmacology, biochemistry and behavior, 2002-01, Vol.71 (1), p.223-231

2002

Volltextzugriff (PDF)

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5542-5551

2005

Volltextzugriff (PDF)

Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma

Journal of clinical oncology, 2001-01, Vol.19 (2), p.305-313

2001

Volltextzugriff (PDF)

Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses

Science translational medicine, 2012-06, Vol.4 (137), p.137ra74

2012

Volltextzugriff (PDF)

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Cell, 2017-11, Vol.171 (4), p.934-949.e16

2017

Volltextzugriff (PDF)

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

Annals of the New York Academy of Sciences, 2013-07, Vol.1291 (1), p.1-13

2013

Volltextzugriff (PDF)

Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40

Clinical cancer research, 2017-10, Vol.23 (20), p.6165-6177

2017

Volltextzugriff (PDF)

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF -Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134

Journal of clinical oncology, 2023-01, Vol.41 (2), p.186-197

2023

Volltextzugriff (PDF)

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2005-01, Vol.23 (1), p.133-141

2005

Volltextzugriff (PDF)

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment

Journal of translational medicine, 2013-03, Vol.11 (1), p.54-54, Article 54

2013

Volltextzugriff (PDF)

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer cell, 2020-10, Vol.38 (4), p.500-515.e3

2020

Volltextzugriff (PDF)

Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response

Annals of oncology, 2019-04, Vol.30 (4), p.589-596

2019

Volltextzugriff (PDF)

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

The New England journal of medicine, 2010-08, Vol.363 (8), p.711-723

2010

Volltextzugriff (PDF)

1 – 25 von 355

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(337)
Mit Volltextzugriff
(271)

Publikationsform

Sprache

Englisch
(351)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(198)
Life Sciences & Biomedicine
(187)
Humans
(186)
Female
(113)
Oncology
(110)
Biological And Medical Sciences
(103)
Medical Sciences
(97)
Male
(93)
Middle Aged
(82)
Aged
(69)
Adult
(64)
Pharmacology. Drug Treatments
(55)
Animals
(52)
Antineoplastic Agents
(50)
Immunotherapy
(50)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(44)
Treatment Outcome
(37)
Neoplasms - Therapy
(33)
Immunology
(31)
Tumors
(30)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fusobacterium nucleatum ist im Magen nachweisbar und ist mit schlechterer Prognose beim Magenkarzinom vom diffusen Typ assoziiert

P569 Fecal Microbiome Transplantation for Recurrent C. difficile Colitis: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series

Distinct microbiota in patients diagnosed with colorectal cancer compared to healthy individuals

Distinct composition and distribution of the gastric mycobiota observed between dyspeptic and gastric cancer patients evaluated from gastric biopsies

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes

Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review

Assessing fear of recurrence of esophageal cancer in patients treated with esophagectomy

Thromboembolic Events Before Esophagectomy for Esophageal Cancer Do Not Result in Worse Outcomes

Therapeutic interventions for vitiligo

Preoperative Chemoradiation for the Treatment of Locoregional Esophageal Cancer: The Standard of Care?

Delaying surgery for esophageal cancer increases postoperative complications

Propranolol and metoprolol enhance the anticonvulsant action of valproate and diazepam against maximal electroshock

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma

Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF -Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Suchergebnisse filtern